Khursheed Anwer - 17 Mar 2023 Form 4 Insider Report for Imunon, Inc. (IMNN)

Role
Chief Scientific Officer
Signature
/s/ Kimberly Bragg, VP of Finance & Controller
Issuer symbol
IMNN
Transactions as of
17 Mar 2023
Net transactions value
$0
Form type
4
Filing time
21 Mar 2023, 16:38:43 UTC
Next filing
18 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNN Stock Option (Right to Buy) Award $0 +40,000 +88% $0.000000 85,688 17 Mar 2023 Common Stock 40,000 $1.32 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant.
F2 Represents the closing price of Imunon, Inc. Common Stock on the date of grant.